Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

被引:241
作者
De Rycke, L
Peene, I
Hoffman, IEA
Kruithof, E
Union, A
Meheus, L
Lebeer, K
Wyns, B
Vincent, C
Mielants, H
Boullart, L
Serre, G
Veys, EM
De Keyser, F
机构
[1] Ghent Univ Hosp, Dept Rheumatol, B-9000 Ghent, Belgium
[2] Innogenet NV, Ghent, Belgium
[3] Univ Toulouse 3, Purpan Sch Med, INSERM, CJF 96 02,IFR30, F-31062 Toulouse, France
[4] Univ Ghent, Dept Elect Energy Syst & Automat, B-9000 Ghent, Belgium
关键词
D O I
10.1136/ard.2003.017574
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Autoantibodies such as rheumatoid factor (RF) and anticitrullinated protein antibodies can be detected in rheumatoid arthritis (RA) sera. Objective: To determine the diagnostic values of RF, anticitrullinated protein antibodies, and the shared epitope (SE), and their associations with radiological progression rates and extra-articular manifestations. Methods: Population 1 consisted of sera from 315 patients, consecutively sent for detection of anticitrullinated protein antibodies, of which 264 were used to determine the sensitivity and specificity of RF and of antibodies against three synthetic citrullinated peptides: peptide A (pepA), peptide B (pepB), and CCP2. Population 2 consisted of sera from 180 longstanding RA patients and was used to determine associations of RA associated antibodies and the SE with radiological progression rates and extra-articular manifestations. Antibodies to pepA and pepB were detected by line immunoassay, and antibodies to CCP2 by ELISA. HLA Class II typing was performed by LiPA. Results: In population 1, we defined adapted cut offs corresponding to a specificity of greater than or equal to98.5%. This yielded the following sensitivities: RF 12.8%; anti-pepA antibodies 63.6%; anti-pepB antibodies 54.2%; and anti-CCP2 antibodies 73.7%. In population 2, significant differences in radiological progression rates were found between positive and negative patients for different RA antibodies and the SE. RF, but not anticitrullinated protein antibodies or the SE, were more frequent in patients with extra-articular manifestations. Conclusion: A valid comparison of RA associated antibodies shows superior sensitivity of the anticitrullinated protein antibodies compared with RF. The presence of RA associated antibodies and the SE are indicative for poorer radiological outcome, and presence of extra-articular manifestations is associated with RF but not with anticitrullinated protein antibodies.
引用
收藏
页码:1587 / 1593
页数:7
相关论文
共 41 条
  • [11] 2-G
  • [12] Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule
    Hill, JA
    Southwood, S
    Sette, A
    Jevnikar, AM
    Bell, DA
    Cairns, E
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (02) : 538 - 541
  • [13] Hulsmans HMJ, 2000, ARTHRITIS RHEUM, V43, P1927, DOI 10.1002/1529-0131(200009)43:9<1927::AID-ANR3>3.0.CO
  • [14] 2-B
  • [15] Jansen ALMA, 2002, J RHEUMATOL, V29, P2074
  • [16] Kaltenhäuser S, 2001, J RHEUMATOL, V28, P735
  • [17] Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO
  • [18] 2-6
  • [19] Infliximab and methotrexate in the treatment of rheumatoid arthritis
    Lipsky, PE
    van der Heijde, DMFM
    St Clair, EW
    Furst, DE
    Breedveld, FC
    Kalden, JR
    Smolen, JS
    Weisman, M
    Emery, P
    Feldmann, M
    Harriman, GR
    Maini, RN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22) : 1594 - 1602
  • [20] Mattey DL, 2001, ARTHRITIS RHEUM, V44, P1529, DOI 10.1002/1529-0131(200107)44:7<1529::AID-ART275>3.0.CO